Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Erosive Esophagitis [Phase 3]

View source ↗

Summary

A Phase 3 study testing the efficacy and safety of BLI5100 in patients with erosive esophagitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erosive Esophagitis

Drugs mentioned

• BLI5100

Snippet

Sponsor: Braintree Laboratories | Conditions: Erosive Esophagitis | Phase 3 | Status: COMPLETED